Cargando…
Photobiomodulation Improves Serum Cytokine Response in Mild to Moderate COVID-19: The First Randomized, Double-Blind, Placebo Controlled, Pilot Study
BACKGROUND: Because the major event in COVID-19 is the release of pre- and inflammatory cytokines, finding a reliable therapeutic strategy to inhibit this release, help patients manage organ damage and avoid ICU admission or severe disease progression is of paramount importance. Photobiomodulation (...
Autores principales: | Marashian, Seyed Mehran, Hashemian, Mohammadreza, Pourabdollah, Mihan, Nasseri, Mansour, Mahmoudian, Saeed, Reinhart, Florian, Eslaminejad, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304695/ https://www.ncbi.nlm.nih.gov/pubmed/35874678 http://dx.doi.org/10.3389/fimmu.2022.929837 |
Ejemplares similares
-
Primary Gastrointestinal Involvement in a Case of Extranodal-Extranasal Natural Killer T Cell Lymphoma
por: Lookzadeh, Somayeh, et al.
Publicado: (2020) -
Determination of optimal time for reading of rapid urease test diagnosis of Helicobacter pylori
por: Eslaminejad, Alireza, et al.
Publicado: (2020) -
Efficacy of Low-Dose Ciclesonide and Fluticasone Propionate for Mild to Moderate Persistent Asthma
por: Jamaati, Hamidreza, et al.
Publicado: (2015) -
Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial
por: Hafizi, Maryam, et al.
Publicado: (2023) -
Transmission electron microscopy study of suspected primary ciliary dyskinesia patients
por: Rezaei, Mitra, et al.
Publicado: (2022)